Abstract
Orexinergic and norepinephrinergic α 2-adrenoceptor expressing neurons contribute to the regulation of the sleep–wakefulness cycle. In the present study, we have examined a possible interaction between orexinergic and α 2-adrenergic systems in orexin-A (100 nM)- and K + (25 mM)-evoked norepinephrine release from slices of rat cerebrocortex. In this tissue norepinephrinergic neurons are predominantly innervated via the locus coeruleus. Clonidine concentration-dependently inhibited K +-evoked norepinephrine release with pIC 50 ( I max) of 6.44 ± 0.38 (48.8 ± 6.9%). A selective orexin-1 receptor antagonist, SB-334867 was ineffective. SB-334867 concentration-dependently inhibited orexin A-evoked norepinephrine release with pIC 50 ( I max) of 6.05 ± 0.14 (86.4 ± 5.4%); clonidine (α 2-agonist) was ineffective. In contrast, yohimbine reversed the inhibitory effects of clonidine (1 μM) on K +-evoked norepinephrine release with pIC 50 ( I max) of 6.50 ± 0.34 (77.6 ± 10.9%); orexin A was ineffective. The present data suggest a lack of interaction between orexinergic and α 2-adrenergic neurons in rat cerebral cortex.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.